RNXT vs MDAI
Comparison between RenovoRx Inc (RNXT, Company) and Spectral AI Inc - Class A (MDAI, Company).
Both RNXT and MDAI are from the Healthcare sector.
5-Year PerformanceRNXT has outperformed MDAI, delivering a return of -29.0% compared to -30.2%
RNXT vs MDAI - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
RNXT vs MDAI - Historical Returns
Returns include dividend reinvestment.
RNXT vs MDAI - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | RNXT | MDAI |
|---|---|---|
| 2026 | +58.05% | +10.34% |
| 2025 | -38.23% | -47.99% |
| 2024 | -34.85% | +11.86% |
| 2023 | -13.58% | -75.52% |
| 2022 | -52.04% | +2.85% |
| 2021 | -33.33% | +1.13% |
RNXT vs MDAI Drawdown Comparison
The maximum drawdown for RNXT was -96.25%, occurring on Nov 17, 2023. This drawdown has not yet recovered.
The maximum drawdown for MDAI was -93.49%, occurring on Sep 24, 2024. This drawdown has not yet recovered.
The current RNXT drawdown is -91.76%. The current MDAI drawdown is -88.91%.
| Rank | RNXT | MDAI |
|---|---|---|
| #1 | -96.25% Aug 30, 2021 - Nov 17, 2023 | -93.49% Sep 7, 2023 - Sep 24, 2024 |
| #2 | N/A | -29.39% Apr 14, 2023 - Sep 7, 2023 |
| #3 | N/A | -6.99% Apr 12, 2023 - Apr 14, 2023 |
| #4 | N/A | -2.73% Jan 5, 2023 - Apr 11, 2023 |
| #5 | N/A | -2.68% Dec 19, 2022 - Dec 23, 2022 |
| #6 | N/A | -2.39% May 14, 2021 - Nov 17, 2021 |
| #7 | N/A | -1.86% Dec 28, 2022 - Jan 5, 2023 |
| #8 | N/A | -1.62% Nov 30, 2021 - Oct 13, 2022 |
| #9 | N/A | -1.02% May 4, 2021 - May 14, 2021 |
| #10 | N/A | -0.92% Apr 7, 2021 - May 3, 2021 |
| #11 | N/A | -0.49% Dec 23, 2022 - Dec 28, 2022 |
| #12 | N/A | -0.40% Oct 26, 2022 - Nov 9, 2022 |
| #13 | N/A | -0.20% Nov 29, 2022 - Dec 19, 2022 |
| #14 | N/A | -0.10% Nov 19, 2021 - Nov 24, 2021 |
| #15 | N/A | -0.10% Oct 14, 2022 - Oct 21, 2022 |
Correlation
Correlation between RNXT and MDAI is 0.62 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks